XML 36 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Accounting for Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Share-based Compensation Expense

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in millions):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

Effect on income before income taxes

 

$

(6

)

 

$

(5

)

Effect on net loss

 

$

(5

)

 

$

(4

)

Schedule of Share-based Payment Awards, Stock Options, Valuation Assumptions

The fair value of stock options was estimated using the Black Scholes option pricing model with the following assumptions and weighted-average fair values during the three months ended March 31, 2023 and 2022:

 

 

 

Three Months Ended

March 31,

 

 

 

2023

 

 

2022

 

Expected volatility

 

87.3%

 

 

84.3% - 87.5%

 

Expected dividends

 

 

 

 

Expected term

 

6 years

 

 

3 - 6 years

 

Risk-free interest rate

 

4.2%

 

 

1.5% - 1.6%

 

Schedule of Share-based Compensation, Stock Options, Activity

Options outstanding and exercisable under the 2009 Plan as of March 31, 2023, and changes during the three-month period following December 31, 2022, was as follows (in millions, except share and per share data):

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Average

 

Intrinsic

 

 

 

 

 

 

 

Average

 

 

Remaining

 

Value as of

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

March 31,

 

 

 

Shares

 

 

Price

 

 

Term

 

2023

 

Outstanding at December 31, 2022

 

 

2,831,751

 

 

$

7.32

 

 

 

 

 

 

 

Granted

 

 

814,000

 

 

 

6.15

 

 

 

 

 

 

 

Exercised

 

 

(8,334

)

 

 

4.97

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2023

 

 

3,637,417

 

 

$

7.06

 

 

8.1 years

 

$

 

Exercisable at March 31, 2023

 

 

2,078,661

 

 

$

6.46

 

 

7.2 years

 

$

 

Schedule of Share-based Compensation, Restricted Stock, Activity

Restricted stock outstanding under the 2009 Plan as of March 31, 2023, and changes during the three-month period following December 31, 2022, was as follows:

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2022

 

 

5,541,065

 

 

$

8.53

 

Granted

 

 

2,651,000

 

 

 

6.14

 

Vested

 

 

(2,076,569

)

 

 

6.77

 

Forfeited

 

 

(10,001

)

 

 

9.31

 

Unvested at March 31, 2023

 

 

6,105,495

 

 

 

8.09

 

Schedule of Share-based Compensation, Restricted Stock Units, Activity

RSUs outstanding under the 2009 Plan as of March 31, 2023, and changes during the three-month period following December 31, 2022, was as follows:

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2022

 

 

512,360

 

 

$

7.54

 

Granted

 

 

365,037

 

 

 

6.15

 

Vested

 

 

(95,577

)

 

 

7.92

 

Forfeited

 

 

 

 

 

 

Unvested at March 31, 2023

 

 

781,820

 

 

 

6.84